[PHARMACOLOGY IN PREGNANCY. II].
D000014:Abnormalities, Drug-Induced; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D005260:Female; D005315:Fetal Diseases; D006634:Histamine H1 Antagonists; D006728:Hormones; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid; D008431:Maternal-Fetal Exchange; D009581:Nitrofurans; D010600:Pharmacology; D011247:Pregnancy; D011803:Quinine; D013449:Sulfonamides; D014116:Toxicology; D014611:Vaccination; D014815:Vitamins
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D006634:Histamine H1 Antagonists; D006728:Hormones; D009581:Nitrofurans; D013449:Sulfonamides; D014815:Vitamins; D011803:Quinine; D007538:Isoniazid
ABNORMALITIES, DRUG-INDUCED; ANTIBIOTICS; ANTIHISTAMINICS; ANTINEOPLASTIC AGENTS; FETAL DISEASES; HORMONES; INFANT, NEWBORN; ISONIAZID; MATERNAL-FETAL EXCHANGE; NITROFURANS; PHARMACOLOGY; PREGNANCY; QUININE; REVIEW; SULFONAMIDES; TOXICOLOGIC REPORT; VACCINATION; VITAMINS
FARMACOLOGIA IN GRAVIDANZA. II.